Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study

BACKGROUND: Selective serotonergic reuptake inhibitors (SSRIs) are first-line pharmacologic treatments for patients with posttraumatic stress disorder (PTSD), but must be given over extended period of time before the onset of action. The use of SSRIs in PTSD patients with mild traumatic brain injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Muhammad R., Beck, Robert D., Wilson, Jennifer L., Lemmer, Jennifer A., Meraj, Adeel, Meyer, Eric C., Mintz, Jim, Peterson, Alan L., Roache, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545554/
https://www.ncbi.nlm.nih.gov/pubmed/33032657
http://dx.doi.org/10.1186/s40779-020-00278-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545554/
https://www.ncbi.nlm.nih.gov/pubmed/33032657
http://dx.doi.org/10.1186/s40779-020-00278-0

Ejemplares similares